Cell cycle dependency of caspase activation in Fas-induced apoptosis in leukemia cells

Cancer Science

Volumn 98, Issue 8, 2007, Pages 1174-1183

  Li, Yufeng ^a   Dida, Francis ^a   Iwao, Atsushi ^a   Deguchi, Takao ^a   Azuma, Eiichi ^a,b   Komada, Yoshihiro ^a,b  

^a MIE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b MIE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CASPASE 8; CYCLIN A; CYCLIN B1; CYCLIN E; FAS ANTIGEN; KI 67 ANTIGEN; PROTEIN P27;

APOPTOSIS; ARTICLE; CANCER GROWTH; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL CYCLE PROGRESSION; CELL CYCLE S PHASE; CONTROLLED STUDY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; LEUKEMIA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; WESTERN BLOTTING;

ANTIGENS, CD95; APOPTOSIS; CASPASE 3; CASPASE 8; CASPASES; CELL CYCLE; CYCLINS; ENZYME ACTIVATION; G1 PHASE; HUMANS; LEUKEMIA; TUMOR CELLS, CULTURED;

EID: 34347257822     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2007.00523.x     Document Type: Article

References (44)

1. Chinnaiyan AM, O'Rourke K, Tewari M, Dixit VM. FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell 1995; 81: 505-12.
2. Muzio M, Chinnaiyan AM, Kischkel FC et al. FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/ APO-1) death-inducing signaling complex. Cell 1996; 85: 817-27.
3. Scaffidi C, Fulda S, Srinivasan A et al. Two CD95 (APO-1/Fas) signaling pathways. EMBO J 1998; 17: 1675-87.
4. Li H, Zhu H, Xu CJ, Yuan J. Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell 1998; 94: 491-501.
5. Li P, Nijhawan D, Budihardjo I, Srinivasula SM, Ahmad M, Alnemri ES, Wang X. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 1997; 91: 479-89.
6. Liu X, Zou H, Slaughter C, Wang X. DFF, a heterodimeric protein that functions downstream of caspase-3 to trigger DNA fragmentation during apoptosis. Cell 1997; 89: 175-84.
7. Gong J, Traganos F, Darzynkiewicz Z. Threshold expression of cyclin E but not D type cyclins characterizes normal and tumour cells entering S phase. Cell Prolif 1995; 28: 337-46.
8. Ohtsubo M, Theodoras AM, Schumacher J, Roberts JM, Pagano M. Human cyclin E, a nuclear protein essential for the G 1 -to-S phase transition. Mol Cell Biol 1995; 15: 2612-24.
9. Dulic V, Lees E, Reed SI. Association of human cyclin E with a periodic G 1 -S phase protein kinase. Science 1992; 257: 1958-61.
10. Yam CH, Fung TK, Poon RY. Cyclin A in cell cycle control and cancer. Cell Mol Life Sci 2002; 59: 1317-26.
11. Hwang A, Maity A, McKenna WG, Muschel RJ. Cell cycle-dependent regulation of the cyclin B1 promoter. J Biol Chem 1995; 270: 28 419-24.
12. Maity A, McKenna WG, Muschel RJ. Evidence for post-transcriptional regulation of cyclin B1 mRNA in the cell cycle and following irradiation in HeLa cells. EMBO J 1995; 14: 603-9.
13. Darzynkiewicz Z, Gong J, Juan G, Ardelt B, Traganos F. Cytometry of cyclin proteins. Cytometry 1996; 25: 1-13.
14. Gong J, Traganos F, Darzynkiewicz Z. Discrimination of G 2 and mitotic cells by flow cytometry based on different expression of cyclins A and B1. Exp Cell Res 1995; 220: 226-31.
15. Meikrantz W, Schlegel R. Apoptosis and the cell cycle. J Cell Biochem 1995; 58: 160-74.
16. Russell JH. Activation-induced death of mature T cells in the regulation of immune responses. Curr Opin Immunol 1995; 7: 382-8.
17. Janssen O, Sanzenbacher R, Kabelitz D. Regulation of activation-induced cell death of mature T-lymphocyte populations. Cell Tissue Res 2000; 301: 85-99.
18. Li QS, Tanaka S, Kisenge RR, Toyoda H, Azuma E, Komada Y. Activation-induced T cell death occurs at G1A phase of the cell cycle. Eur J Immunol 2000; 30: 3329-37.
19. Komada Y, Zhou YW, Zhang XL et al. Fas receptor (CD95)-mediated apoptosis is induced in leukemic cells entering G1B compartment of the cell cycle. Blood 1995; 86: 3848-60.
20. Komada Y, Sakurai M. Fas receptor (CD95)-mediated apoptosis in leukemic cells. Leuk Lymphoma 1997; 25: 9-21.
21. Lopez F, Belloc F, Lacombe F et al. Modalities of synthesis of Ki67 antigen during the stimulation of lymphocytes. Cytometry 1991; 12: 42-9.
22. Agrawal D, Hauser P, McPherson F, Dong F, Garcia A, Pledger WJ. Repression of p27kip1 synthesis by platelet-derived growth factor in BALB/c 3T3 cells. Mol Cell Biol 1996; 16: 4327-36.
23. Beletskaya IV, Nikonova LV, Beletsky IP. Cell cycle specificity of Fas-mediated apoptosis in WIL-2 cells. FEBS Lett 1997; 412: 91-3.
24. Algeciras-Schimnich A, Griffith TS, Lynch DH, Paya CV. Cell cycle-dependent regulation of FLIP levels and susceptibility to Fas-mediated apoptosis. J Immunol 1999; 162: 5205-11.
25. Kuntzen C, Sonuc N, De Toni EN et al. Inhibition of c-Jun-N-terminal-kinase sensitizes tumor cells to CD95-induced apoptosis and induces G 2/M cell cycle arrest. Cancer Res 2005; 65: 6780-8.
26. Dao T, Huleatt JW, Hingorani R, Crispe IN. Specific resistance of T cells to CD95-induced apoptosis during S phase of the cell cycle. J Immunol 1997; 159: 4261-7.
27. Hueber A, Durka S, Weller M. CD95-mediated apoptosis: No variation in cellular sensitivity during cell cycle progression. FEBS Lett 1998; 432: 155-7.
28. Meng XW, Heldebrant MP, Kaufmann SH. Phorbol 12-myristate 13-acetate inhibits death receptor-mediated apoptosis in Jurkat cells by disrupting recruitment of Fas-associated polypeptide with death domain. J Biol Chem 2002; 277: 3776-83.
29. Toyoshima H, Hunter T. p27, a novel inhibitor of G 1 cyclin-Cdk protein kinase activity, is related to p21. Cell 1994; 78: 67-74.
30. Coats S, Flanagan WM, Nourse J, Roberts JM. Requirement of p27Kip1 for restriction point control of the fibroblast cell cycle. Science 1996; 272: 877-80.
31. Decker T, Schneller F, Hipp S et al. Cell cycle progression of chronic lymphocytic leukemia cells is controlled by cyclin D2, cyclin D3, cyclin-dependent kinase (cdk) 4 and the cdk inhibitor p27. Leukemia 2002; 16: 327-34.
32. Mohapatra S, Agrawal D, Pledger WJ. p27Kip1 regulates T cell proliferation. J Biol Chem 2001; 276: 21.976-83.
33. Tsukiyama T, Ishida N, Shirane M et al. Down-regulation of p27Kip1 expression is required for development and function of T cells. J Immunol 2001; 166: 304-12.
34. Fournel S, Genestier L, Robinet E, Flacher M, Revillard JP. Human T cells require IL-2 but not G 1/S transition to acquire susceptibility to Fas-mediated apoptosis. J Immunol 1996; 157: 4309-15.
35. Irmler M, Thome M, Hahne M et al. Inhibition of death receptor signals by cellular FLIP. Nature 1997; 388: 190-5.
36. Grayson JM, Zajac AJ, Altman JD, Ahmed R. Cutting edge: Increased expression of Bcl-2 in antigen-specific memory CD8+ T cells. J Immunol 2000; 164: 3950-4.
37. Grayson JM, Harrington LE, Lanier JG, Wherry EJ, Ahmed R. Differential sensitivity of naive and memory CD8+ T cells to apoptosis in.vivo. J Immunol 2002; 169: 3760-70.
38. Belanger S, Cote M, Lane D, L'Esperance S, Rancourt C, Piche A. Bcl-2 decreases cell proliferation and promotes accumulation of cells in S phase without affecting the rate of apoptosis in human ovarian carcinoma cells. Gynecol Oncol 2005; 97: 796-806.
39. Cheng N, Janumyan YM, Didion L, Van Hofwegen C, Yang E, Knudson CM. Bcl-2 inhibition of T-cell proliferation is related to prolonged T-cell survival. Oncogene 2004; 23: 3770-80.
40. Cao Q, Xia Y, Azadniv M, Crispe IN. The E2F-1 transcription factor promotes caspase-8 and bid expression, and enhances Fas signaling in T cells. J Immunol 2004; 173: 1111-17.
41. Alenzi FQ. Links between apoptosis, proliferation and the cell cycle. Br J Biomed Sci 2004; 61: 99-102.
42. Hingorani R, Bi B, Dao T, Bae Y, Matsuzawa A, Crispe IN. CD95/Fas signaling in T lymphocytes induces the cell cycle control protein p21 cip-1/WAF-1, which promotes apoptosis. J Immunol 2000; 164: 4032-6.
43. Suzuki A, Tsutomi Y, Akahane K, Araki T, Miura M. Resistance to Fas-mediated apoptosis: Activation of caspase 3 is regulated by cell cycle regulator p21WAF1 and IAP gene family ILP. Oncogene 1998; 17: 931-9.
44. Suzuki A, Tsutomi Y, Miura M, Akahane K. Caspase 3 inactivation to suppress Fas-mediated apoptosis: Identification of binding domain with p21 and ILP and inactivation machinery by p21. Oncogene 1999; 18: 1239-44.